Halozyme Therapeutics shares owned by Bridgefront Capital
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Bridgefront Capital
from 13F filings
Historical chart of Bridgefront Capital investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Bridgefront Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Bridgefront Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $500k | 6.8k | 73.34 |
| 2025-06-30 | $339k | 6.5k | 52.02 |
| 2023-09-30 | $238k | 6.2k | 38.20 |
| 2021-06-30 | $419k | 9.2k | 45.40 |
| 2021-03-31 | $212k | 5.1k | 41.67 |
| 2020-12-31 | $513k | 12k | 42.74 |